Therapeutic Nuclear Drug Market, Global Outlook and Forecast 2023-2029

Report ID: MMG175121 | Category: Pharma & Healthcare | Pages: 61 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Nuclear Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Nuclear Drug. This report contains market size and forecasts of Therapeutic Nuclear Drug in global, including the following market information:
Global Therapeutic Nuclear Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Therapeutic Nuclear Drug market was valued at US$ 1719.4 million in 2022 and is projected to reach US$ 2152.8 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 47%, followed by Europe and Asia-Pacว
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Therapeutic Nuclear Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Therapeutic Nuclear Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Therapeutic Nuclear Drug Market Segment Percentages, by Type, 2022 (%)
    Radium-223
    Lutetium-177
    Iodine-131
    Other
Global Therapeutic Nuclear Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Therapeutic Nuclear Drug Market Segment Percentages, by Application, 2022 (%)
    Thyroid
    Bone Metastasis
    Lymphoma
    Other
Global Therapeutic Nuclear Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Therapeutic Nuclear Drug Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Therapeutic Nuclear Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Therapeutic Nuclear Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Bayer
    Novartis
    China Isotope & Radiation
    Dongcheng
    Q BioMed
    Curium Pharmaceuticals
    Jubilant DraxImage
    Lantheus
    Spectrum Pharmaceuticals
    Progenics Pharmaceuticals
    International Isotopes
Outline of Major Chapters:
Chapter 1: Introduces the definition of Therapeutic Nuclear Drug, market overview.
Chapter 2: Global Therapeutic Nuclear Drug market size in revenue.
Chapter 3: Detailed analysis of Therapeutic Nuclear Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Therapeutic Nuclear Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Therapeutic Nuclear Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Therapeutic Nuclear Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Therapeutic Nuclear Drug Overall Market Size
    2.1 Global Therapeutic Nuclear Drug Market Size: 2022 VS 2029
    2.2 Global Therapeutic Nuclear Drug Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Therapeutic Nuclear Drug Players in Global Market
    3.2 Top Global Therapeutic Nuclear Drug Companies Ranked by Revenue
    3.3 Global Therapeutic Nuclear Drug Revenue by Companies
    3.4 Top 3 and Top 5 Therapeutic Nuclear Drug Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Therapeutic Nuclear Drug Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Therapeutic Nuclear Drug Players in Global Market
        3.6.1 List of Global Tier 1 Therapeutic Nuclear Drug Companies
        3.6.2 List of Global Tier 2 and Tier 3 Therapeutic Nuclear Drug Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Therapeutic Nuclear Drug Market Size Markets, 2022 & 2029
        4.1.2 Radium-223
        4.1.3 Lutetium-177
        4.1.4 Iodine-131
        4.1.5 Other
    4.2 By Type - Global Therapeutic Nuclear Drug Revenue & Forecasts
        4.2.1 By Type - Global Therapeutic Nuclear Drug Revenue, 2018-2023
        4.2.2 By Type - Global Therapeutic Nuclear Drug Revenue, 2024-2029
        4.2.3 By Type - Global Therapeutic Nuclear Drug Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Therapeutic Nuclear Drug Market Size, 2022 & 2029
        5.1.2 Thyroid
        5.1.3 Bone Metastasis
        5.1.4 Lymphoma
        5.1.5 Other
    5.2 By Application - Global Therapeutic Nuclear Drug Revenue & Forecasts
        5.2.1 By Application - Global Therapeutic Nuclear Drug Revenue, 2018-2023
        5.2.2 By Application - Global Therapeutic Nuclear Drug Revenue, 2024-2029
        5.2.3 By Application - Global Therapeutic Nuclear Drug Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Therapeutic Nuclear Drug Market Size, 2022 & 2029
    6.2 By Region - Global Therapeutic Nuclear Drug Revenue & Forecasts
        6.2.1 By Region - Global Therapeutic Nuclear Drug Revenue, 2018-2023
        6.2.2 By Region - Global Therapeutic Nuclear Drug Revenue, 2024-2029
        6.2.3 By Region - Global Therapeutic Nuclear Drug Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Therapeutic Nuclear Drug Revenue, 2018-2029
        6.3.2 US Therapeutic Nuclear Drug Market Size, 2018-2029
        6.3.3 Canada Therapeutic Nuclear Drug Market Size, 2018-2029
        6.3.4 Mexico Therapeutic Nuclear Drug Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Therapeutic Nuclear Drug Revenue, 2018-2029
        6.4.2 Germany Therapeutic Nuclear Drug Market Size, 2018-2029
        6.4.3 France Therapeutic Nuclear Drug Market Size, 2018-2029
        6.4.4 U.K. Therapeutic Nuclear Drug Market Size, 2018-2029
        6.4.5 Italy Therapeutic Nuclear Drug Market Size, 2018-2029
        6.4.6 Russia Therapeutic Nuclear Drug Market Size, 2018-2029
        6.4.7 Nordic Countries Therapeutic Nuclear Drug Market Size, 2018-2029
        6.4.8 Benelux Therapeutic Nuclear Drug Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Therapeutic Nuclear Drug Revenue, 2018-2029
        6.5.2 China Therapeutic Nuclear Drug Market Size, 2018-2029
        6.5.3 Japan Therapeutic Nuclear Drug Market Size, 2018-2029
        6.5.4 South Korea Therapeutic Nuclear Drug Market Size, 2018-2029
        6.5.5 Southeast Asia Therapeutic Nuclear Drug Market Size, 2018-2029
        6.5.6 India Therapeutic Nuclear Drug Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Therapeutic Nuclear Drug Revenue, 2018-2029
        6.6.2 Brazil Therapeutic Nuclear Drug Market Size, 2018-2029
        6.6.3 Argentina Therapeutic Nuclear Drug Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Therapeutic Nuclear Drug Revenue, 2018-2029
        6.7.2 Turkey Therapeutic Nuclear Drug Market Size, 2018-2029
        6.7.3 Israel Therapeutic Nuclear Drug Market Size, 2018-2029
        6.7.4 Saudi Arabia Therapeutic Nuclear Drug Market Size, 2018-2029
        6.7.5 UAE Therapeutic Nuclear Drug Market Size, 2018-2029
7 Therapeutic Nuclear Drug Companies Profiles
    7.1 Bayer
        7.1.1 Bayer Company Summary
        7.1.2 Bayer Business Overview
        7.1.3 Bayer Therapeutic Nuclear Drug Major Product Offerings
        7.1.4 Bayer Therapeutic Nuclear Drug Revenue in Global Market (2018-2023)
        7.1.5 Bayer Key News & Latest Developments
    7.2 Novartis
        7.2.1 Novartis Company Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Therapeutic Nuclear Drug Major Product Offerings
        7.2.4 Novartis Therapeutic Nuclear Drug Revenue in Global Market (2018-2023)
        7.2.5 Novartis Key News & Latest Developments
    7.3 China Isotope & Radiation
        7.3.1 China Isotope & Radiation Company Summary
        7.3.2 China Isotope & Radiation Business Overview
        7.3.3 China Isotope & Radiation Therapeutic Nuclear Drug Major Product Offerings
        7.3.4 China Isotope & Radiation Therapeutic Nuclear Drug Revenue in Global Market (2018-2023)
        7.3.5 China Isotope & Radiation Key News & Latest Developments
    7.4 Dongcheng
        7.4.1 Dongcheng Company Summary
        7.4.2 Dongcheng Business Overview
        7.4.3 Dongcheng Therapeutic Nuclear Drug Major Product Offerings
        7.4.4 Dongcheng Therapeutic Nuclear Drug Revenue in Global Market (2018-2023)
        7.4.5 Dongcheng Key News & Latest Developments
    7.5 Q BioMed
        7.5.1 Q BioMed Company Summary
        7.5.2 Q BioMed Business Overview
        7.5.3 Q BioMed Therapeutic Nuclear Drug Major Product Offerings
        7.5.4 Q BioMed Therapeutic Nuclear Drug Revenue in Global Market (2018-2023)
        7.5.5 Q BioMed Key News & Latest Developments
    7.6 Curium Pharmaceuticals
        7.6.1 Curium Pharmaceuticals Company Summary
        7.6.2 Curium Pharmaceuticals Business Overview
        7.6.3 Curium Pharmaceuticals Therapeutic Nuclear Drug Major Product Offerings
        7.6.4 Curium Pharmaceuticals Therapeutic Nuclear Drug Revenue in Global Market (2018-2023)
        7.6.5 Curium Pharmaceuticals Key News & Latest Developments
    7.7 Jubilant DraxImage
        7.7.1 Jubilant DraxImage Company Summary
        7.7.2 Jubilant DraxImage Business Overview
        7.7.3 Jubilant DraxImage Therapeutic Nuclear Drug Major Product Offerings
        7.7.4 Jubilant DraxImage Therapeutic Nuclear Drug Revenue in Global Market (2018-2023)
        7.7.5 Jubilant DraxImage Key News & Latest Developments
    7.8 Lantheus
        7.8.1 Lantheus Company Summary
        7.8.2 Lantheus Business Overview
        7.8.3 Lantheus Therapeutic Nuclear Drug Major Product Offerings
        7.8.4 Lantheus Therapeutic Nuclear Drug Revenue in Global Market (2018-2023)
        7.8.5 Lantheus Key News & Latest Developments
    7.9 Spectrum Pharmaceuticals
        7.9.1 Spectrum Pharmaceuticals Company Summary
        7.9.2 Spectrum Pharmaceuticals Business Overview
        7.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Drug Major Product Offerings
        7.9.4 Spectrum Pharmaceuticals Therapeutic Nuclear Drug Revenue in Global Market (2018-2023)
        7.9.5 Spectrum Pharmaceuticals Key News & Latest Developments
    7.10 Progenics Pharmaceuticals
        7.10.1 Progenics Pharmaceuticals Company Summary
        7.10.2 Progenics Pharmaceuticals Business Overview
        7.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Drug Major Product Offerings
        7.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Drug Revenue in Global Market (2018-2023)
        7.10.5 Progenics Pharmaceuticals Key News & Latest Developments
    7.11 International Isotopes
        7.11.1 International Isotopes Company Summary
        7.11.2 International Isotopes Business Overview
        7.11.3 International Isotopes Therapeutic Nuclear Drug Major Product Offerings
        7.11.4 International Isotopes Therapeutic Nuclear Drug Revenue in Global Market (2018-2023)
        7.11.5 International Isotopes Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Therapeutic Nuclear Drug Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?